A5052123434- LGBTQ Health, Identity, and Policy
- Reproductive Health and Contraception
- Diabetes Treatment and Management
- Sex and Gender in Healthcare
- Reproductive Health and Technologies
- Diabetes Management and Research
- Lipid metabolism and disorders
- DNA Repair Mechanisms
- Pharmacology and Obesity Treatment
- Cervical Cancer and HPV Research
- Bariatric Surgery and Outcomes
- Peroxisome Proliferator-Activated Receptors
- Male Breast Health Studies
- Genetics and Neurodevelopmental Disorders
- Maternal and Perinatal Health Interventions
- Menopause: Health Impacts and Treatments
- BRCA gene mutations in cancer
- Sexuality, Behavior, and Technology
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Sexual Differentiation and Disorders
NYU Langone Health
2024
New York University
2019-2021
University of Colorado Denver
2019-2021
LeadingAge New York
2009
Abstract Context Postbariatric hypoglycemia (PBH), characterized by enteroinsular axis overstimulation and hyperinsulinemic hypoglycemia, is a complication of bariatric surgery for which there no approved therapy. Objective To evaluate efficacy safety avexitide [exendin (9-39)], glucagon-like peptide-1 antagonist, treatment PBH. Methods A multicenter, Phase 2, randomized, placebo-controlled crossover study (PREVENT). Eighteen female patients with PBH were given placebo 14 days followed 30 mg...
Objective The results of the Women’s Health Initiative studies dramatically altered hormone therapy use around world. In countries outside United States, self-use in physicians remained unaltered while prescription declined, implying that may not concur with findings. We wished to explore prevailing attitudes among American by examining New York City obstetrician-gynaecologists’ and therapy. Study design All board-certified obstetrician-gynaecologists were invited complete return a detailed,...
Despite increased media attention to transgender/gender non-binary people, access care remains a major health disparity. Several multidisciplinary gender clinics involve children/adolescents seeing multiple providers during the same visit. However, adult transgender are more primary care-based with navigators guiding patients across specialties. Few exist where for single We know of no published models housed within endocrine clinic, which can serve as gender-inclusive space providers/staff...
Avexitide (formerly exendin 9-39) is a first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist in development as liquid formulation for subcutaneous (SC) injection treatment of post-bariatric hypoglycemia (PBH). PBH, rare disease with high unmet medical need and no approved pharmacologic therapy, develops late complication bariatric surgery. Patients PBH exhibit exaggerated GLP-1 levels dysregulated secretion insulin symptomatic 1-3 hours after meals, putting them at risk severe...